Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway

Published:2022-04 Issue: Volume:294 Page:120370
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Liu Zhan-zhao,Duan Xian-xian,Yuan Meng-ci,Yu Jing,Hu Xiao,Han Xiao,Lan Lan,Liu Bo-wei,Wang Yue,Qin Jun-fang

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference51 articles.

1. Diabetes and breast cancer risk: a meta-analysis;Boyle;Br. J. Cancer,2012

2. Diabetes increases the risk of breast cancer: a meta-analysis;Hardefeldt;Endocr. Relat. Cancer,2012

3. Diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis;Zhao;Medicine (Baltimore),2016

4. Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?;Basha;Exp. Diabetes Res.,2012

5. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs;Gouaze;Cancer Res.,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between NADPH Oxidase 2 (NOX2) and Drug Resistance in Cancer;Current Cancer Drug Targets;2024-12

2. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND);Frontiers in Pharmacology;2024-09-04

3. The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer;Cancer and Metastasis Reviews;2024-05-27

4. Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells;Medical Oncology;2024-05-06

5. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration;Aging;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3